Bronchogen
Bronchogen (Ala-Glu-Asp-Leu) is an advanced Khavinson tetrapeptide bioregulator developed specifically for deep pulmonary restoration. Acting far beyond bronchodilators, it is prescribed in extensive regenerative protocols to physically rebuild damaged lung tissue. Highly effective at combating chronic obstructive pulmonary disease (COPD), severe asthma, and post-viral lung scarring by essentially rebooting local cellular defense mechanisms.
Quick Stats
Scientific Data
Mechanism of Action
Bronchogen (Ala-Glu-Asp-Leu) is a synthetic tetrapeptide bioregulator targeting bronchial and pulmonary epithelium. It normalizes bronchial epithelial cell gene expression disrupted by chronic inflammation. It promotes mucociliary clearance, regulates secretory IgA production, and downregulates pro-inflammatory cytokines in the respiratory tract. Khavinson studies show improved lung function in patients with chronic bronchitis and COPD.
Source: PMID: 15677927
Background & History
Bronchogen (AEDL) targets bronchial epithelium for respiratory health.
Research Use Cases
- ✓COPD support
- ✓Chronic bronchitis
- ✓Respiratory mucosal repair
Dosing Protocol
| Typical Dose | 10-20 mg/day (oral) or 1-2 mg SC |
| Frequency | 1× daily for 10-30 day cycles |
| Half-Life | ~30 minutes (estimated) |
| Common Vial Sizes | 5 mg, 10 mg |
Dosing Protocols
Khavinson Protocol
Body-Weight Dosing Reference
Estimated doses extrapolated from the published research range of 1000–20000 mcg/day (referenced to 70 kg / 154 lb). These are approximations — consult a qualified healthcare provider for personalised guidance.
| Weight | Low Dose | Target Dose | High Dose |
|---|---|---|---|
| 120 lb(54 kg) | 771 mcg | 8100 mcg | 15429 mcg |
| 140 lb(63 kg) | 900 mcg | 9450 mcg | 18000 mcg |
| 160 lb(73 kg) | 1043 mcg | 10950 mcg | 20857 mcg |
| 180 lb(82 kg) | 1171 mcg | 12300 mcg | 23429 mcg |
| 200 lb(91 kg) | 1300 mcg | 13650 mcg | 26000 mcg |
| 220 lb(100 kg) | 1429 mcg | 15000 mcg | 28571 mcg |
| 250 lb(113 kg) | 1614 mcg | 16950 mcg | 32286 mcg |
💉 For exact syringe units based on your vial concentration, use the Bronchogen Reconstitution Calculator →
Administration
Expected Timeline
Who Is It For?
Respiratory / Lung Health
LowBronchial bioregulator. Restores age-suppressed or inflammation-suppressed bronchial gene expression.
Reconstitution Example
Safety & Considerations
Research peptide. Extensively used in Russian clinical protocols. Excellent safety profile.
Regulatory & Legal Status
Not currently on the WADA 2026 Prohibited List. Policies may change — verify before competition.
Research Chemical
US Compounding: Not eligible / not available
⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.
Interactions & Contraindications
Standard Khavinson protocol.
Synergies & Common Stacks
Bronchogen (synthetic) + Taxorest (bronchial Cytomax) = layered respiratory support.
Bronchogen (bronchial epithelium) + Chonluten (alveolar/surfactant) = comprehensive lung bioregulator protocol.
Dosing Quick Reference
Frequently Asked Questions
What does Bronchogen target?▼
References
- Khavinson VKh et al. “"Peptide bioregulators in the treatment of chronic bronchitis".” Advances in Gerontology (2004). PMID: 15570775
📚 Related Articles
Get Bronchogen from Vita-Stream — the comprehensive distributor for authentic Khavinson bioregulators. Oral capsules, no injections required.
Affiliate link · Full review